Seoulin Bioscience Co.,Ltd. (KOSDAQ: 038070)
South Korea
· Delayed Price · Currency is KRW
6,210.00
-10.00 (-0.16%)
Nov 15, 2024, 9:00 AM KST
Seoulin Bioscience Co.,Ltd. Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 14, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 54,476 | 78,767 | 97,546 | 174,747 | 107,487 | 68,537 | |
Market Cap Growth | -25.17% | -19.25% | -44.18% | 62.58% | 56.83% | -9.30% | |
Enterprise Value | 30,939 | 46,863 | 48,995 | 136,075 | 93,693 | 49,869 | |
Last Close Price | 6370.00 | 9200.00 | 11255.64 | 19923.50 | 12186.06 | 7641.78 | |
PE Ratio | - | - | 13.78 | 10.98 | 21.41 | 7.49 | |
Forward PE | - | 19.70 | 19.70 | 19.70 | 19.70 | 19.70 | |
PS Ratio | 0.65 | 0.88 | 0.93 | 2.17 | 1.65 | 1.26 | |
PB Ratio | 0.65 | 0.92 | 1.10 | 2.28 | 1.75 | 1.12 | |
P/TBV Ratio | 0.87 | 0.96 | 1.17 | 2.36 | 1.82 | 1.17 | |
P/FCF Ratio | 12.75 | - | - | 21.89 | 32.74 | 9.72 | |
P/OCF Ratio | 15.28 | 84.64 | - | 19.60 | 29.17 | 9.36 | |
EV/Sales Ratio | 0.37 | 0.52 | 0.47 | 1.69 | 1.44 | 0.92 | |
EV/EBITDA Ratio | 10.90 | 12.39 | 4.80 | 14.51 | 14.52 | 14.43 | |
EV/EBIT Ratio | 21.18 | 18.79 | 5.33 | 18.26 | 20.96 | 27.66 | |
EV/FCF Ratio | 7.24 | - | - | 17.04 | 28.54 | 7.07 | |
Debt / Equity Ratio | 0.03 | 0.08 | 0.20 | 0.21 | 0.01 | 0.00 | |
Debt / EBITDA Ratio | 0.88 | 1.78 | 1.74 | 1.68 | 0.12 | 0.07 | |
Debt / FCF Ratio | 0.57 | - | - | 1.97 | 0.23 | 0.04 | |
Asset Turnover | 0.70 | 0.72 | 0.77 | 0.75 | 0.82 | 0.72 | |
Inventory Turnover | 2.87 | 3.57 | 5.15 | 4.63 | 4.09 | 2.99 | |
Quick Ratio | 2.34 | 1.77 | 1.35 | 1.44 | 2.13 | 1.93 | |
Current Ratio | 3.92 | 2.60 | 1.88 | 1.77 | 3.06 | 2.78 | |
Return on Equity (ROE) | -3.32% | -2.67% | 12.78% | 23.03% | 7.83% | 15.25% | |
Return on Assets (ROA) | 0.73% | 1.25% | 4.23% | 4.34% | 3.52% | 1.48% | |
Return on Capital (ROIC) | 0.89% | 1.57% | 5.78% | 6.03% | 4.52% | 1.90% | |
Earnings Yield | -1.08% | -0.15% | 10.41% | 8.92% | 4.55% | 12.96% | |
FCF Yield | 7.84% | -0.02% | -4.94% | 4.57% | 3.05% | 10.29% | |
Dividend Yield | 1.57% | 1.06% | - | - | - | - | |
Payout Ratio | 0.00% | - | 7.86% | 4.93% | 14.74% | 11.59% | |
Buyback Yield / Dilution | 10.76% | 19.42% | -23.72% | 0.07% | 1.26% | 0.72% | |
Total Shareholder Return | 12.33% | 20.48% | -23.72% | 0.07% | 1.26% | 0.72% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.